Scott B. Ullem, a director at Illumina, Inc., has made a notable decision regarding his compensation by choosing to receive his third-quarter retainer fees in the form of company stock. This move underscores a growing trend among executives to align their compensation with the performance of their companies, potentially enhancing shareholder value.

The decision was documented in a recent SEC filing, which revealed that Ullem received 113 shares of Illumina stock, valued at approximately $219.80 per share. Following this transaction, Ullem now holds a total of 11,143 shares in the company. This choice to accept stock instead of cash reflects a commitment to the long-term success of Illumina and aligns his interests with those of shareholders.

Background

Illumina, Inc. is a prominent player in the laboratory analytical instruments sector, specifically classified under the SIC code 3826. The company is headquartered in San Diego, California, and is known for its innovative technologies in the field of genomics and biotechnology. Illumina's stock is traded under the symbol ILMN.

Recent filings show that Ullem's decision comes after a series of transactions, including a previous filing on July 30, 2026, related to his stock holdings. The most recent SEC filing, dated October 2, 2026, is part of a pattern where Ullem has opted for stock compensation, indicating a strategic approach to his earnings.

What the Filing Says

The SEC filing states, "Mr. Ullem elected to receive 100% of his 2026 board and committee cash retainer fees in Illumina stock." This decision is calculated based on the cash compensation payable for the completed quarter divided by the volume-weighted average closing price per share during that period.

Impact

Ullem's choice may influence other executives within the laboratory analytical instruments sector to consider similar compensation strategies. By opting for stock, Ullem demonstrates a commitment to the company's future, which could resonate positively with investors and stakeholders.

What's Next

The filing does not say what happens next.